Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related Measures

Audrey Y. Chu(University of Helsinki), Daniel I. Chasman(Brigham and Women's Hospital), Bryan J. Barratt(AstraZeneca (United Kingdom)), Bo Ding(Karolinska Institutet), Samia Mora(Brigham and Women's Hospital), Paul M. Ridker(Herlev Hospital), Franco Giulianini(Brigham and Women's Hospital), Fredrik Nyberg(National Academy of Medicine)
Circulation Cardiovascular Genetics
August 14, 2015
10.1161/circgenetics.114.000962
Cited by 9

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Biological, clinical and population relevance of 95 loci for blood lipids
|Nature|2010|3.7k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
|Circulation|2003|2.3k